Gene · 3357
Papers2,210
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,210
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pharmacological Mechanism of the Non-hallucinogenic 5-HT2A Agonist Ariadne and Analogs. | ACS Chem Neurosci | 2023 | 36521179 | PubTator, text mining | PubMed |
| Influence of Perioperative Anesthesia on Cancer Recurrence: from Basic Science to Clinical Practice. | Curr Oncol Rep | 2023 | 36512273 | PubTator, text mining | PubMed |
| Use of the head-twitch response to investigate the structure-activity relationships of 4-thio-substituted 2,5-dimethoxyphenylalkylamines. | Psychopharmacology (Berl) | 2023 | 36477925 | PubTator, text mining | PubMed |
| Serotonin-releasing agents with reduced off-target effects. | Mol Psychiatry | 2023 | 36352123 | PubTator, text mining | PubMed |
| Annual Research Review: Perspectives on progress in ADHD science - from characterization to cause. | J Child Psychol Psychiatry | 2023 | 36220605 | PubTator, text mining | PubMed |
| miRNA-203b-3p Induces Acute and Chronic Pruritus through 5-HTR2B and TRPV4. | J Invest Dermatol | 2023 | 36049541 | PubTator, text mining | PubMed |
Modulation of GPCR receptors common to gut inflammatory diseases and neuronal disorders, Alzheimer's and Parkinson's diseases as druggable targets through Withania somnifera bioactives: an in silico study. | J Biomol Struct Dyn | 2023 | 35491707 | PubTator, text mining | PubMed |
| Mini Review on Cariprazine: A Promising Antipsychotic Agent. | CNS Neurol Disord Drug Targets | 2023 | 35331126 | PubTator, text mining | PubMed |
| Understanding and countering opioid-induced respiratory depression. | Br J Pharmacol | 2023 | 34089181 | PubTator, text mining | PubMed |
| Psychedelics for Alzheimer's Disease Palliative Care. | Adv Psychiatry Behav Health | 2022 | 37786540 | PubTator, text mining | PubMed |
| Serotonin receptor subtype-2B signaling is associated with interleukin-18-induced cardiomyoblast hypertrophy in vitro. | Asian Biomed (Res Rev News) | 2022 | 37551283 | PubTator, text mining | PubMed |
| Dopamine agonist therapy for prolactinomas: do we need to rethink the place of surgery in prolactinoma management? | Endocr Oncol | 2022 | 37435462 | PubTator, text mining | PubMed |
| CD47-blocking Antibody ZL-1201 Promotes Tumor-associated Macrophage Phagocytic Activity and Enhances the Efficacy of the Therapeutic Antibodies and Chemotherapy. | Cancer Res Commun | 2022 | 36970051 | PubTator, text mining | PubMed |
| Pulmonary Arterial Hypertension: Emerging Principles of Precision Medicine across Basic Science to Clinical Practice. | Rev Cardiovasc Med | 2022 | 36875282 | PubTator, text mining | PubMed |
| Exercise reduces the anxiogenic effects of meta-chlorophenylpiperazine: The role of 5-HT2C receptors in the bed nucleus of the stria terminalis. | Front Synaptic Neurosci | 2022 | 36713088 | PubTator, text mining | PubMed |
| Myocardial Cell Preservation from Potential Cardiotoxic Drugs: The Role of Nanotechnologies. | Pharmaceutics | 2022 | 36678717 | PubTator, text mining | PubMed |
| Regeneration of Pancreatic β-Cells for Diabetes Therapeutics by Natural DYRK1A Inhibitors. | Metabolites | 2022 | 36676976 | PubTator, text mining | PubMed |
| Identification of immune- and autophagy-related genes and effective diagnostic biomarkers in endometriosis: a bioinformatics analysis. | Ann Transl Med | 2022 | 36660690 | PubTator, text mining | PubMed |
| Hypertrophic cardiomyopathy induces changes in the tryptophan-5-hydroxylase, serotonin transporter and serotonergic receptors expressions. | Gac Med Mex | 2022 | 36657118 | PubTator, text mining | PubMed |
| Serial femtosecond crystallography. | Nat Rev Methods Primers | 2022 | 36643971 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3357/papers?page=17